첨단바이오 포커스

국민의 안전과 건강을 지키는 한국의약품안전관리원

홈 > 알림마당 > 뉴스레터 > 첨단바이오 포커스

인쇄
게시글 보기
제목 첨단바이오 포커스 제1호
등록자 hyelin 등록일 2021-01-08 조회수 361

References

1. 식품의약품안전처 홈페이지 Available from: https://www.mfds.go.kr/brd/m_210/view.do?seq=14679&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=2
2. 편집부 기자. 줄기세포, 유전자치료 등 첨단재생의료 치료 기반 마련!, 이엠디 메디컬 뉴스(2020.11.18.), Available from: http://www.mdon.co.kr/news/article.html?no=30556
3. 박경은. 정세균 총리 “정부, 희귀·난치병 환자 치료 ‘기회의 문’ 넓혀야”, 아주경제(2020.12.03.). Available from: https://www.ajunews.com/view/20201203110708963
4. 보건복지부 보도자료 Available from : http://www.mohw.go.kr/react/al/sal0301vw.jsp?PAR_MENU_ID=04&MENU_ID=0403&page=1&CONT_SEQ=361614
5. “Genome Editing and Advanced Manufacturing of Hematopoietic Stem Cell-Based Therapeutics” US FDA. Last modified Nov 6, 2020, Accessed Dec 9, 2020 Available
https://www.fda.gov/vaccines-blood-biologics/biologics-research-projects/genome-editing-and-advanced-manufacturing-hematopoietic-stem-cell-based-therapeutics
6. “Qualification Process for Drug Development Tools Guidance for Industry and FDA Staff” US FDA. Last modified Nov. 24, 2020, Accessed Dec. 9, 2020 Available from:
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/qualification-process-drug-development-tools-guidance-industry-and-fda-staff
7. “Committee for Advanced Therapies (CAT): 4-6 November 2020” EMA. Accessed Dec. 9, 2020 Available from: https://www.ema.europa.eu/en/events/committee-advanced-therapies-cat-4-6-november-2020
8. “Zolgensma” EMA. Accessed Dec. 9, 2020 Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/zolgensma
9. “Alofisel” EMA. Accessed Dec 9. 2020 Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/alofisel
10. “What’s new” EMA. Accessed Dec. 9, 2020 Available from: https://www.ema.europa.eu/en/news-events/whats-new/2020-11
11. “Review Reports: Regenerative Medical Products” PMDA. Accsesed Dec. 9, 2020 Available from: https://www.pmda.go.jp/english/review-services/reviews/approved-information/0004.html
12. Wang Dan, et al. Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov. 2019 May;18(5):358-378
13. Santiago-Ortiz JL, Schaffer DV. Adeno-Associated Virus (AAV) Vectors in Cancer Gene Therapy. J Control Release. 2016 Oct 28;240:287-301
14. Xiubin He et al. Basic and Clinical Application of Adeno-Associated Virus-Mediated Genome Editing. Hum Gene Ther. 2019 Jun;30(6):673-681.
15. Naso MF, et al. Adeno-Associated Virus(AAV) as a Vector for Gene Therapy. BioDrugs. 2017 Aug;31(4):317-334.

첨부파일
첨단바이오 포커스 제1호 (21년 1월).pdf [26616781 byte]